Wogonin Suppresses Non-Small Cell Lung Cancer Growth in Association with Oxidative Stress, c-Myc/GPX4 Downregulation

Hairong Xiang1, Haoshu Liu1, Ruyu Jiang1

  • 1College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Insights

Wogonin (WGN) combats non-small cell lung cancer (NSCLC) by increasing reactive oxygen species (ROS), inducing ferroptosis, and triggering apoptosis. This flavonoid targets key proteins, offering a potential therapeutic strategy for NSCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Antioxidant defense regulated by reactive oxygen species (ROS) is crucial in non-small cell lung cancer (NSCLC) progression and treatment resistance.
  • Wogonin (WGN), a flavonoid, exhibits antitumor properties, but its role in ROS-dependent ferroptosis and mitochondrial stress in NSCLC requires further investigation.

Purpose of the Study:

  • To elucidate the association between Wogonin (WGN) and ROS-dependent ferroptotic and mitochondrial stress in non-small cell lung cancer (NSCLC).
  • To investigate the molecular mechanisms underlying WGN's effects on NSCLC cell lines, xenografts, and patient-derived organoids.

Main Methods:

  • Utilized NSCLC cell lines (A549, BEAS-2B), mouse xenografts, patient-derived organoids, and transcriptomic data.
  • Assessed cell viability, colony formation, migration, invasion, ROS levels, mitochondrial potential, apoptosis, iron, and lipid peroxidation.
  • Employed RT-qPCR, Western blotting, immunofluorescence, and c-Myc gain/loss-of-function assays.

Main Results:

  • WGN inhibited A549 cell growth and motility, increasing intracellular ROS, iron (Fe2+), and lipid peroxidation.
  • WGN decreased mitochondrial membrane potential, induced apoptosis, and downregulated c-Myc, GPX4, and SLC7A11 while upregulating ACSL4.
  • Inhibitor rescue experiments and c-Myc manipulation confirmed WGN's impact on ferroptosis and apoptosis pathways.

Conclusions:

  • Wogonin (WGN) suppresses NSCLC phenotypes, particularly in A549 cells, through ROS accumulation, ferroptosis induction, and mitochondrial dysfunction-associated apoptosis.
  • The observed effects are linked to the downregulation of the c-Myc/GPX4 axis, highlighting a novel therapeutic mechanism for WGN in NSCLC.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...